Dueling Selectively With Darwin

Turning points in my intellectual life have never been welcome; I always seem to resist them until forced to do otherwise. One such passage occurred some 10 years ago, as I was walking one spring morning in the Downs of southern England with the evolutionary biologist John Maynard Smith and his biologist wife Sheila. John, remarking on our proximity to Charles Darwin’s home, chided me gently: “You really must think about natural selection, Stuart.” How his comment shocked me

Written byStuart Kauffman
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Turning points in my intellectual life have never been welcome; I always seem to resist them until forced to do otherwise. One such passage occurred some 10 years ago, as I was walking one spring morning in the Downs of southern England with the evolutionary biologist John Maynard Smith and his biologist wife Sheila. John, remarking on our proximity to Charles Darwin’s home, chided me gently: “You really must think about natural selection, Stuart.”

How his comment shocked me! Of course I should think about it! But I had spent more than a decade exploring the idea that much biological order might reflect inherent self-organized properties of complex systems, even in the absence of selection. Since Darwin, of course, we have come to view natural selection, sifting out rare useful mutations from myriads of useless ones, as the sole source of order in biological systems.

But is this view correct? ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies